Fampridine
Lords · Question HL3466 · Tabled 14 Sep 2026 · Department of Health and Social Care · Official record
Answered 25 Sep 2026
Question
Asked by Lord Bowness
To ask His Majesty's Government what are the eligibility criteria for a patient with multiple sclerosis to be prescribed Fampridine for a trial period; and what plans they have to fund ongoing treatment on terms similar to those in Wales, Scotland and Nor
Answer
Answered by Baroness Merron, 25 Sep 2026
NHS England published a clinical commissioning policy in July 2026 recommending prolonged-release fampridine as a routine commissioning treatment option for adults in England with multiple sclerosis (MS) and associated walking impairment who meet the defi...